Baseline characteristics | AL (2002–2012) | AS-AQ (1999–2012) | DP (2003–2011) | Total (1999–2012) |
---|---|---|---|---|
Patients (N) | 13,664 (46.3Â %) | 11,337 (38.4Â %) | 4,492 (15.2Â %) | 29,493 |
Female | 6,437 (47.1Â %) | 5,322 (46.9Â %) | 2,123 (47.3Â %) | 13,882 (47.1Â %) |
Age | Â | Â | Â | Â |
Mean age ± SD (years) | 7.4 ± 9.22 | 6.6 ± 8.60 | 4.9 ± 7.51 | 6.7 ± 8.78 |
<1Â year | 795 (5.8Â %) | 842 (7.4Â %) | 447 (10.0Â %) | 2,084 (7.1Â %) |
1 to <5Â years | 7,183 (52.6Â %) | 6,324 (55.8Â %) | 3,185 (70.9Â %) | 16,692 (56.6Â %) |
5 to <12Â years | 3,184 (23.3Â %) | 2,357 (20.8Â %) | 432 (9.6Â %) | 5,973 (20.3Â %) |
≥12 years | 2,478 (18.1 %) | 1,801 (15.9 %) | 427 (9.5 %) | 4,706 (16.0 %) |
Geographic region | Â | Â | Â | Â |
East Africa | 6,040 (44.2Â %) | 2,920 (25.8Â %) | 2,229 (49.6Â %) | 11,189 (37.9Â %) |
West Africa | 6,481 (47.4Â %) | 6,749 (59.5Â %) | 1,302 (29.0Â %) | 14,532 (49.3Â %) |
Central Africa | 483 (3.5Â %) | 758 (6.7Â %) | 174 (3.9Â %) | 1,415 (4.8Â %) |
South Africa | 660 (4.8Â %) | 910 (8.0Â %) | 787 (17.5Â %) | 2,357 (8.0Â %) |
Transmission settings | Â | Â | Â | Â |
High | 4,836 (35.4Â %) | 4,062 (35.8Â %) | 1,876 (41.8Â %) | 10,774 (36.5Â %) |
Low/moderate | 8,828 (64.6Â %) | 7,275 (64.2Â %) | 2,616 (58.2Â %) | 18,719 (63.5Â %) |
Enrolment clinical parameters | Â | Â | Â | Â |
Mean body weight ± SD (kg) | 21.2 ± 16.23 | 19.5 ± 15.26 | 16.3 ± 13.72 | 19.8 ± 15.59 |
Median parasitaemia (IQR) | 19,260 (5,930–48,260) | 20,000 (6,080–52,480) | 25,540 (8,320–59,830) | 20,200 (6,320–51,520) |
Parasitaemia >100,000/μL | 8.4 % (1,152/13,664) | 10.7 % (1,209/11,337) | 11.7 % (527/4,492) | 9.8 % (2,888/29,493) |
Mean haemoglobin ± SD (g/dl) | 10.3 ± 2.17 | 9.7 ± 2.10 | 9.6 ± 1.86 | 9.9 ± 2.11 |
Gametocytes presence | 8.2Â % (868/10,649) | 11.1Â % (821/7,428) | 9.1Â % (394/4,325) | 9.3Â % (2,083/22,402) |
Elevated temperature (>37.5 °C) | 61.9 % (7,861/12,691) | 67.3 % (7,461/11,092) | 63.7 % (2,814/4,419) | 64.3 % (18,136/28,202) |
Anaemia | Â | Â | Â | Â |
Moderate | 44Â % (4,246/9,650) | 48.6Â % (3,761/7,734) | 52.7Â % (2,159/4,095) | 47.3Â % (10,166/21,479) |
Severe | 6.9Â % (666/9,650) | 10.1Â % (780/7,734) | 7.5Â % (306/4,095) | 8.2Â % (1,752/21,479) |